Fanella, G., Baiata, C., Candeloro, E., Toscano, G., Colnaghi, S., Mauri, M., et al. (2022) New-Onset Myasthenia Gravis after mRNA SARS-CoV-2 Vaccination: A Case Series. Neurological Sciences, 43, 5799-5802.
https://doi.org/10.1007/s10072-022-06284-5

has been cited by the following article:

• TITLE: Post-Vaccination Myasthenia Gravis and Vaquez Disease

  AUTHORS: Alassane Mamadou Diop, Ahmadou Bamba Mbodj, Daouda Thioub, Jamil Kawahgi, Maouly Fall

  KEYWORDS: SARS-CoV2, Myasthenia, JAK2

  JOURNAL NAME: Neuroscience and Medicine, Vol.16 No.2, June 25, 2025

  ABSTRACT: We report the case of a 68-year-old patient who developed autoimmune myasthenia 24 hours after receiving the second dose of an inactivated SARS-CoV-2 vaccine (Sinopharm®). This patient, already followed for ischemic heart disease, presented with typical symptoms such as diplopia, bilateral ptosis, and muscle fatigability upon exertion. Investigations revealed the presence of anti-acetylcholine receptor antibodies as well as polycythemia, confirmed by the JAK2 V617F mutation, suggesting an association with a myeloproliferative disorder.